This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

All-Trans Retinoic Acid

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What All-Trans Retinoic Acid Means in Everyday Medical Language

All-trans retinoic acid (ATRA) is a natural substance made in the body from vitamin A. It helps cells grow and develop properly, which is especially important during early stages of life, such as when a baby is developing in the womb. Because it supports healthy cell function, ATRA is sometimes called vitamin A acid or tretinoin. The body needs only small amounts of it, but it plays a big role in how cells behave and mature.

Why All-Trans Retinoic Acid Matters in Cancer Care

In cancer care, ATRA is important because it is used as a medicine to treat a specific type of blood cancer called acute promyelocytic leukemia (APL). APL is a fast-growing cancer where immature blood cells called promyelocytes build up in the bone marrow and blood without maturing properly. ATRA helps these immature cells mature into healthy blood cells, which can improve the disease and how the body fights it. This makes ATRA a key part of treatment plans for patients with APL. It is also being studied for use in other cancers, but its main approved use is for this leukemia.

What Patients Might See or Hear About All-Trans Retinoic Acid

Patients might come across the term all-trans retinoic acid or ATRA in their medical reports, treatment plans, or medication lists. It may also appear in clinical trial descriptions or drug information sheets. Sometimes it is mentioned when discussing skin treatments, as ATRA is used in creams for acne. Hearing or reading the term can feel confusing, but it usually relates to how cells grow or how a specific cancer is treated. It’s important to understand that seeing this term does not automatically mean a patient has cancer or is being treated with ATRA.

How Doctors Use All-Trans Retinoic Acid in Care

Doctors use ATRA mainly to treat acute promyelocytic leukemia. It helps immature blood cells mature properly, which is important for controlling the disease. ATRA may be part of diagnosis and treatment planning, and doctors may monitor how well it is working during follow-up care. It can also appear in discussions about clinical trials exploring new uses or combinations of this medicine. Understanding its role helps patients see how ATRA fits into their overall care.

Common Names and Possible Confusions

All-trans retinoic acid is known by several names, including ATRA, tretinoin, retinoic acid, and vitamin A acid. These names refer to the same or very similar substances but may be used in different settings. For example, tretinoin is often the name used when the medicine is applied to the skin for acne, while ATRA is more common in cancer treatment discussions. Knowing these different names can help avoid confusion when reading medical information or talking with healthcare providers.

Questions to Ask Your Healthcare Team

If you hear about all-trans retinoic acid in your care, it can help to ask your healthcare team questions like: What role does this medicine play in my treatment? How is it different from regular vitamin A supplements? What side effects should I watch for? Can it interact with other medicines I am taking? These questions can help you feel more informed and involved in your care decisions.

Understanding the Term in Context and Safety Considerations

Seeing the term all-trans retinoic acid in your medical records or treatment plan usually relates to its role in helping cells mature properly. However, it is important to use this medicine only as directed by your healthcare provider. Taking it without medical supervision, especially in high doses, can cause side effects or interfere with other treatments. This information is meant to help you understand the term but does not replace advice from your doctor or pharmacist. Always follow your care team’s instructions and report any unusual symptoms promptly.

Next Steps for Patients and Caregivers

If you have heard about all-trans retinoic acid in your cancer care or skin treatment, the best next step is to talk openly with your healthcare providers. They can explain why it is recommended, what to expect, and how to manage any side effects. Being informed and asking questions can help you feel more confident and supported throughout your care journey.

Sources

Public source information used for this glossary entry includes: